Literature DB >> 24670235

CRP levels in extremely low birth weight (ELBW) septic infants.

K Dritsakou1, G Liosis, M Gioni, E Glynou, K Avdeliodi, K Papagaroufalis.   

Abstract

OBJECTIVE: Testing the validity of C-reactive protein (CRP) in extremely low birth weight (ELBW) infants.
METHODS: During a five-year period, 483 infants with probable (36%) and definite sepsis (64%) were enrolled in the study.
RESULTS: ELBW infants with definitive sepsis had CRP levels comparable with full-terms (p=0.992). However, the highest (hs) values were observed in infants >2500 g, 24 h after the septic work up whereas in those with birth weight (BW) <1000 g after 48 h. Highest CRP levels of infants with early sepsis were similar to those of the late onset ones (p=0.825). The causative microorganism had a strong influence on CRP values, as Gram negative germs produced significantly higher CRP levels in comparison to infants with Gram positive sepsis.
CONCLUSIONS: Highest CRP values in <1000 g infants increase in levels comparable to full terms, but with a 24-h delay.

Entities:  

Keywords:  CRP; ELBW; full term; gram; infants; microorganism

Mesh:

Substances:

Year:  2014        PMID: 24670235     DOI: 10.3109/14767058.2014.908842

Source DB:  PubMed          Journal:  J Matern Fetal Neonatal Med        ISSN: 1476-4954


  3 in total

1.  Clinical and Laboratory Findings of Nosocomial Sepsis in Extremely Low Birth Weight Infants According to Causative Organisms.

Authors:  Kyung-Hee Park; Su-Jung Park; Mi-Hye Bae; Seong-Hee Jeong; Mun-Hui Jeong; Narae Lee; Young-Mi Han; Shin-Yun Byun
Journal:  J Clin Med       Date:  2022-01-04       Impact factor: 4.241

2.  C-reactive protein for late-onset sepsis diagnosis in very low birth weight infants.

Authors:  Marc Beltempo; Isabelle Viel-Thériault; Roseline Thibeault; Anne-Sophie Julien; Bruno Piedboeuf
Journal:  BMC Pediatr       Date:  2018-01-30       Impact factor: 2.125

3.  An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.

Authors:  Louise F Hill; Mark A Turner; Irja Lutsar; Paul T Heath; Pollyanna Hardy; Louise Linsell; Evelyne Jacqz-Aigrain; Emmanuel Roilides; Mike Sharland
Journal:  Trials       Date:  2020-04-15       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.